SCHEMBL4625310

SCHEMBL4625310

O=C(N[C@@H](Cc1ccc2nc(-c3c(Cl)cccc3Cl)ccc2c1)C(=O)O)c1ccc(CNC2CCS(=O)(=O)C2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 8/20 0.62
ITGAV P06756 2/20 0.62
ITGA4 P13612 5/20 0.43
ITGB7 P26010 4/20 0.43
PTPN1 P18031 3/20 0.39
CA2 P00918 1/20 0.39
ALDH1A1 P00352 1/20 0.38
HTT P42858 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
JAK1 P23458 2/20 0.38
ITGA5 P08648 2/20 0.38
ITGB3 P05106 1/20 0.38
SCN3A Q9NY46 1/20 0.37
CCKBR P32239 1/20 0.37
KDM4E B2RXH2 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
ABL1 P00519 1/20 0.36
DGAT2 Q96PD7 1/20 0.35
PTPN2 P17706 1/20 0.35
CDC25B P30305 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4625309 0.93 ITGB1 (0.63) ITGB1ITGAVITGA4ITGB7PTPN1
SCHEMBL4419511 0.82 ITGB1 (0.83) ITGB1ITGAVITGA4ITGB7PTPN1
SCHEMBL3312947 0.79 ITGB1 (0.67) ITGB1ITGAVITGA4ITGB7PTPN1
SCHEMBL3313373 0.78 ITGB1 (1.00) ITGB1ITGAVITGA4ITGB7ITGA5
SCHEMBL3313356 0.78 ITGB1 (1.00) ITGB1ITGAVITGA4ITGB7ITGA5
SCHEMBL8352229 0.78 ITGB1 (1.00) ITGB1ITGAVITGA4ITGB7ITGA5
SCHEMBL3316398 0.78 ITGB1 (1.00) ITGB1ITGAVITGA4ITGB7ITGA5
SCHEMBL4625016 0.76 ITGB1 (0.72) ITGB1ITGAVITGA4ITGB7PTPN1
SCHEMBL4625467 0.75 ITGB1 (0.66) ITGB1ITGAVITGA4ITGB7PTPN1
SCHEMBL3316690 0.74 ITGB1 (0.85) ITGB1ITGAVITGA4ITGB7PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1501801-B1 2,6-QUINOLINYL AND 2,6-NAPHTHYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF VLA-4 DEPENDENT DISEASES UCB PHARMA SA (BE) 2008-01-23 EP disclosed
EP-1870402-A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors UCB Pharma, S.A. (BE) 2007-12-26 EP disclosed